Regions Financial's Preferreds Reviewed: 2 Buys, 1 Hold — Negative
RF Seeking Alpha — November 18, 2025Regions Financial Corporation offers three preferred stock issues—C, E, and F series—with strong dividend coverage and high equity-to-par ratios. RF preferreds provide higher yields than larger banks, reflecting perceived risk, but current financials show no concerns about missed payments or default. All three RF preferreds are BB+ rated, non-cumulative, and offer varying coupons, call dates, and features for different investor preferences and risk tolerances.
PSEG Declares Regular Quarterly Dividend for the Fourth Quarter of 2025 — Neutral
PEG PRNewsWire — November 18, 2025NEWARK, N.J. , Nov. 18, 2025 /PRNewswire/ -- The Board of Directors of Public Service Enterprise Group (NYSE: PEG) today declared a $0.63 per share dividend on the outstanding common stock of the company for the fourth quarter of 2025.
Pearl Diver Credit Company Inc. Announces Third Quarter 2025 Financial Results — Neutral
PDCC PDPA PRNewsWire — November 18, 2025- Company to Host Conference Call and Webcast at 11:00 AM ET Today - NEW YORK and LONDON , Nov. 18, 2025 /PRNewswire/ -- Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA) (the "Company") today announced financial results for the third quarter ended September 30, 2025. "Despite near-term industry headwinds associated with the First Brands bankruptcy, our portfolio delivered increased sequential recurring cash flows in excess of distributions and expenses," said Indranil Basu, Chief Executive Officer of Pearl Diver Credit Company.
Pop-Tarts® Ups the Ante with 'The Biggest Sacrifice Ever' as Six Edible Mascots Take the Field at the 2025 Pop-Tarts™ Bowl — Neutral
K PRNewsWire — November 18, 2025The Pop-Tarts Bowl returns with more mascots, more unforgettable moments and more ways to be a part of the action. Key Points: Delivering on two years of fan demand, the 2025 Pop-Tarts Bowl is being dubbed The People's National Championship.
Leidos to participate in the Goldman Sachs Industrials and Materials Conference — Neutral
LDOS PRNewsWire — November 18, 2025Live audio webcast available on Dec. 3, 2025, from 12:10 p.m. to 12:45 p.m.
Labaton Keller Sucharow LLP Announces a Proposed Class Action Settlement Involving Purchasers of the Publicly Traded Common Stock of Opendoor Technologies Inc. — Neutral
OPEN PRNewsWire — November 18, 2025NEW YORK , Nov. 18, 2025 /PRNewswire/ -- The following statement is being issued by Labaton Keller Sucharow LLP regarding notice of a proposed class action settlement. UNITED STATES DISTRICT COURT DISTRICT OF ARIZONA IN RE OPENDOOR TECHNOLOGIES INC.
Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health — Neutral
DNA PRNewsWire — November 18, 2025BOSTON , Nov. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year initiative funded by the Advanced Research Projects Agency for Health (ARPA-H). The collaboration, Microbe/phage Investigation for Generalized Health TherapY (MIGHTY), aims to develop innovative new treatments for oral health by leveraging Ginkgo's advanced capabilities in working with complex microbial consortia.
Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals — Neutral
ACXP PRNewsWire — November 18, 2025The objective of this new phase of collaboration with Leiden University Medical Center (LUMC) is to further advance the recently completed and published pioneering research to determine whether the modes of DNA polymerase pol IIIC (PolC) action and resistance are conserved across important species of Gram-positive multidrug resistant organisms The previous LUMC-Acurx Health~Holland project successfully elucidated the structure of PolC from E. faecium, a critical Gram-positive human pathogen, in complex with two Acurx pol IIIC inhibitors.
Tom Lee's Fundstrat Capital Expands Granny Shots ETF Lineup-- GRNJ and GRNI Will Begin Trading Today on NYSE Arca — Neutral
ICE PRNewsWire — November 18, 2025NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Fundstrat Capital announces the launch of the Fundstrat Granny Shots US Small- & Mid-Cap ETF ("SMID Granny") (Ticker: GRNJ) and the Fundstrat Granny Shots US Large Cap & Income ETF ("Granny Income") (Ticker: GRNI), both of which will begin trading today on NYSE Arca. These two new ETFs expand Fundstrat's thematic Granny Shots lineup, offering investors diversified exposure informed by the firm's evidence-based research and the macro themes shaping markets.
CGI partners with government organizations across Florida to drive modernization with CGI Advantage® — Neutral
GIB PRNewsWire — November 18, 2025MIAMI , Nov. 18, 2025 /PRNewswire/ -- CGI (TSX: GIB.A) (NYSE: GIB), one of the largest independent technology and professional services firms in the world, today announced significant project milestones at government organizations across Florida that have deployed CGI Advantage ®, a unified ERP platform that delivers efficient financial operations, automates budget processes, streamlines human resource management, and simplifies vendor engagement. "The adoption of CGI Advantage in Florida reflects our ongoing commitment to delivering innovative solutions that advance and support the critical missions of local government agencies," said Tom van der Leest, Senior Vice-President, Consulting Services of CGI's U.S. South …
Toyota Boosts Hybrid Production with $912 Million Investment Creating 252 New U.S. Manufacturing Jobs — Neutral
TM PRNewsWire — November 18, 2025More jobs, investments in Toyota's West Virginia, Kentucky, Missouri and Tennessee plants Hybrid-electric Corollas coming to Mississippi PLANO, Texas , Nov. 18, 2025 /PRNewswire/ -- Toyota's U.S. manufacturing presence is expanding again to meet growing demand for hybrid vehicles. As a part of Toyota's recent commitment to invest up to $10 billion in the U.S. over the next five years, the company announces a $912 million investment and 252 new jobs across five manufacturing plants to increase hybrid capacity and bring hybrid-electric Corollas to its production lineup.
Mines D'Or Orbec Announces Filing and Mailing of its Management Information Circular in Connection with the Special Meeting of Securityholders to Approve the Acquisition by IAMGOLD — Neutral
BLTMF IAG Newsfile Corp — November 18, 2025•Your vote is important no matter how many votes you hold.•The Board of Directors of Orbec recommends that Securityholders vote IN FAVOUR of the Arrangement Resolution.
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference — Neutral
ENTX GlobeNewsWire — November 18, 2025JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company's Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the 8th Annual Evercore ISI Healthcare Conference, details as below.
Vizsla Royalties Congratulates Vizsla Silver on the Positive Feasibility Study for the Panuco Project — Neutral
VZLA Newsfile Corp — November 18, 2025Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - Vizsla Royalties Corp. (TSXV: VROY) (OTCQB: VROYF) ("Vizsla Royalties" or the "Company") congratulates Vizsla Silver Corp.("Vizsla Silver") on the positive results of the Feasibility Study on their flagship Panuco project in Sinaloa, Mexico ("Panuco"). "We are thrilled with the strength of the feasibility study and what it means for Vizsla Royalties royalty on Panuco" stated Michael Pettingell, CEO of Vizsla Royalties.
Cheer Holding Forms Special Committee to Evaluate the Two Preliminary Non-Binding Proposals to Acquire All of Its Shares — Neutral
CHR GlobeNewsWire — November 18, 2025BEIJING, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced that its Board of Directors (the “Board”) has formed a special committee (the “Special Committee”) to, among other things, evaluate (i) the preliminary non-binding proposal letter, dated November 1, 2025, that it received from Zhongsheng Dingxin Investment Fund Management (Beijing) Co., Ltd., an existing shareholder of the Company, proposing to acquire all of the outstanding Class A ordinary shares of the Company, par value $0.001 per share (“Class A Shares”) …
Disguise Celebrates Three Consecutive Years as the #1 Costume Manufacturer YTD in the U.S., with Minecraft securing their Top License Spot, According to Circana — Neutral
JAKK GlobeNewsWire — November 18, 2025POWAY, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Disguise, Inc., the global costume division of leading toy and consumer products company JAKKS Pacific, Inc. (NASDAQ: JAKK), today announced that it has been ranked the #1 costume manufacturer in the U.S. for year-to-date (YTD) 2025, according to Circana (Source: Circana, LLC, Retail Tracking Service, Costumes Supercategory, Dollars Adjusted, Jan–Sept 2025 and Jan 2023–Dec 2024). This marks the third consecutive year Disguise has held the top spot, after previously rising from #2 in 2022 (Source: Circana, LLC, Retail Tracking Service, Costumes Supercategory, Dollars Adjusted, Jan–Sept 2025 vs. Jan–Dec 2022).
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed — Neutral
NSRX GlobeNewsWire — November 18, 2025The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics of NS002 against EpiPen
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference — Neutral
MBX GlobeNewsWire — November 18, 2025CARMEL, Ind., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present and participate in the 37th Annual Piper Sandler Healthcare Conference being held on December 2-4.
SCHMID wins Innovation Award productronica 2025 for InfinityLine L+ — Neutral
SHMD GlobeNewsWire — November 18, 2025SCHMID Group is proud to announce that its InfinityLine L+ has been awarded the Innovation Award productronica 2025 in the category Cluster PCB & EMS.
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference — Neutral
INMB GlobeNewsWire — November 18, 2025Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentations at the upcoming 18th Clinical Trials on Alzheimer's Disease conference (CTAD), in San Diego, CA on December 1-4, 2025.